Cargando…

Has_circ_0008583 modulates hepatocellular carcinoma progression through the miR-1301-3p/METTL3 pathway

Has_circ_0008583 is reported to be involved in the progression of hepatocellular carcinoma (HCC), while its biological role in HCC remains unclear. Here, the qRT-PCR was used to detect the expression of has_circ_0008583. The CCK-8 kit was performed to measure cell proliferation. The cell migration a...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Fenfen, Xie, Zhengyuan, Zhang, Nuobei, Ding, Hao, Xiong, Kai, Guo, Li, Huang, Hongyan, Wen, Zhili
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8805961/
https://www.ncbi.nlm.nih.gov/pubmed/35258395
http://dx.doi.org/10.1080/21655979.2021.2017579
_version_ 1784643339376656384
author Wang, Fenfen
Xie, Zhengyuan
Zhang, Nuobei
Ding, Hao
Xiong, Kai
Guo, Li
Huang, Hongyan
Wen, Zhili
author_facet Wang, Fenfen
Xie, Zhengyuan
Zhang, Nuobei
Ding, Hao
Xiong, Kai
Guo, Li
Huang, Hongyan
Wen, Zhili
author_sort Wang, Fenfen
collection PubMed
description Has_circ_0008583 is reported to be involved in the progression of hepatocellular carcinoma (HCC), while its biological role in HCC remains unclear. Here, the qRT-PCR was used to detect the expression of has_circ_0008583. The CCK-8 kit was performed to measure cell proliferation. The cell migration and invasion were evaluated by Transwell. A dual-luciferase reporter assay was performed to confirm the target combination between the genes in has_circ_0008583/miR-1301-3p/METTL3 axis. The in vivo role of has_circ_0008583 was verified by murine xenograft assay. Our data showed that hsa_circ_0008583 was upregulated in HCC tissues and cells. Hsa_circ_0008583 overexpression promoted Hep3B cell proliferation, migration and invasion, but hsa_circ_0008583 silencing had an opposing influence. MiR-1301-3p is directly bound to hsa_circ_0008583 and METTL3. MiR-1301-3p overexpression or METTL3 knockdown could partially counteract hsa_circ_0008583 overexpression-mediated influence on HCC cell behaviors. In addition, hsa_circ_0008583 depletion inhibits HCC tumor growth in vivo. In conclusion, hsa_circ_0008583 promotes HCC progression through the miR-1301-3p/METTL3 axis.
format Online
Article
Text
id pubmed-8805961
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Taylor & Francis
record_format MEDLINE/PubMed
spelling pubmed-88059612022-02-02 Has_circ_0008583 modulates hepatocellular carcinoma progression through the miR-1301-3p/METTL3 pathway Wang, Fenfen Xie, Zhengyuan Zhang, Nuobei Ding, Hao Xiong, Kai Guo, Li Huang, Hongyan Wen, Zhili Bioengineered Research Paper Has_circ_0008583 is reported to be involved in the progression of hepatocellular carcinoma (HCC), while its biological role in HCC remains unclear. Here, the qRT-PCR was used to detect the expression of has_circ_0008583. The CCK-8 kit was performed to measure cell proliferation. The cell migration and invasion were evaluated by Transwell. A dual-luciferase reporter assay was performed to confirm the target combination between the genes in has_circ_0008583/miR-1301-3p/METTL3 axis. The in vivo role of has_circ_0008583 was verified by murine xenograft assay. Our data showed that hsa_circ_0008583 was upregulated in HCC tissues and cells. Hsa_circ_0008583 overexpression promoted Hep3B cell proliferation, migration and invasion, but hsa_circ_0008583 silencing had an opposing influence. MiR-1301-3p is directly bound to hsa_circ_0008583 and METTL3. MiR-1301-3p overexpression or METTL3 knockdown could partially counteract hsa_circ_0008583 overexpression-mediated influence on HCC cell behaviors. In addition, hsa_circ_0008583 depletion inhibits HCC tumor growth in vivo. In conclusion, hsa_circ_0008583 promotes HCC progression through the miR-1301-3p/METTL3 axis. Taylor & Francis 2022-01-04 /pmc/articles/PMC8805961/ /pubmed/35258395 http://dx.doi.org/10.1080/21655979.2021.2017579 Text en © 2022 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. https://creativecommons.org/licenses/by-nc/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial License (http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) ), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Paper
Wang, Fenfen
Xie, Zhengyuan
Zhang, Nuobei
Ding, Hao
Xiong, Kai
Guo, Li
Huang, Hongyan
Wen, Zhili
Has_circ_0008583 modulates hepatocellular carcinoma progression through the miR-1301-3p/METTL3 pathway
title Has_circ_0008583 modulates hepatocellular carcinoma progression through the miR-1301-3p/METTL3 pathway
title_full Has_circ_0008583 modulates hepatocellular carcinoma progression through the miR-1301-3p/METTL3 pathway
title_fullStr Has_circ_0008583 modulates hepatocellular carcinoma progression through the miR-1301-3p/METTL3 pathway
title_full_unstemmed Has_circ_0008583 modulates hepatocellular carcinoma progression through the miR-1301-3p/METTL3 pathway
title_short Has_circ_0008583 modulates hepatocellular carcinoma progression through the miR-1301-3p/METTL3 pathway
title_sort has_circ_0008583 modulates hepatocellular carcinoma progression through the mir-1301-3p/mettl3 pathway
topic Research Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8805961/
https://www.ncbi.nlm.nih.gov/pubmed/35258395
http://dx.doi.org/10.1080/21655979.2021.2017579
work_keys_str_mv AT wangfenfen hascirc0008583modulateshepatocellularcarcinomaprogressionthroughthemir13013pmettl3pathway
AT xiezhengyuan hascirc0008583modulateshepatocellularcarcinomaprogressionthroughthemir13013pmettl3pathway
AT zhangnuobei hascirc0008583modulateshepatocellularcarcinomaprogressionthroughthemir13013pmettl3pathway
AT dinghao hascirc0008583modulateshepatocellularcarcinomaprogressionthroughthemir13013pmettl3pathway
AT xiongkai hascirc0008583modulateshepatocellularcarcinomaprogressionthroughthemir13013pmettl3pathway
AT guoli hascirc0008583modulateshepatocellularcarcinomaprogressionthroughthemir13013pmettl3pathway
AT huanghongyan hascirc0008583modulateshepatocellularcarcinomaprogressionthroughthemir13013pmettl3pathway
AT wenzhili hascirc0008583modulateshepatocellularcarcinomaprogressionthroughthemir13013pmettl3pathway